Almost one-third of people with moderate to severe psoriasis suffer from mental health issues including depression and anxiety. Now a new digital self-help tool (Claro) has been launched that offers clinically validated mental wellbeing support to those living with psoriasis.
Developed by a specialist team of scientists, physicians, and gaming experts, Claro uses cognitive behavioural therapy, positive psychology, and mindfulness to improve the wellbeing of psoriasis patient.
Psoriasis is a chronic skin condition affecting 1 in 50 people in the UK. Common characteristics include raised ‘plaques’ on the skin, which can be flaky, scaly, itchy and red on Caucasian skin or darker patches on darker skin tones. However, the multi-faceted nature of psoriasis means the effects go beyond just visual signs and symptoms.
Psoriasis can impact on emotional and physical wellbeing often leading to low self-esteem, anxiety, and depression. What is more concerning, is that psoriasis is associated with an increased risk of suicidality. Research reveals up to 1 in 10 sufferers contemplate suicide, particularly those who are younger or whose psoriasis is more severe, highlighting the devastating impact of this disease.
Despite various studies highlighting the relationship between psoriasis and mental health issues, these wider effects often go unrecognised; If left untreated, these issues can prevent people from effectively managing their own psoriasis.
Claro has been designed so that Psoriasis sufferers no longer have to feel alone. Whether looking for clinically validated mental wellbeing support or to connect with people others living with psoriasis, patients can join their online community and seek the support they need to improve their wellbeing. Patients have an offering of 7 modules providing a meaningful, fun, and dynamic experience driven by AI technology. With interactive games, activities and guided mediations, each module teaches patients how to cope with psoriasis in a more positive way offering inspiration and informative content.
Claro is a collaboration that has been produced by pharmaceutical company Almirall in partnership with US based digital firm Happify.
Helen McAteer, Chief Executive at the Psoriasis Association comments, “Many people see psoriasis as a condition that only affects the skin and impacts on appearance. Here at the Psoriasis Association, we understand that psoriasis can have a significant effect on a person’s psychological wellbeing and quality of life. Successful treatment is more than just management of physical symptoms; social support, self-acceptance and mental health resources are vital to those living with chronic conditions such as psoriasis. As a result, we encourage people with psoriasis to consider using helpful support resources such as Claro to help improve their overall wellbeing and quality of life.”
